Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2013 Jan 9;3(4):299–308. doi: 10.1007/s13346-012-0124-9

Figure 7.

Figure 7

Cellular retention of doxorubicin in PC3 cell lines showing a comparison of differential and enhanced accumulation of dox when formulated in nanoparticluate form.